Top

BMC Nephrology

Published in:

Open Access 01-12-2022 | Mood Disorders | Research

The mediating effect of sleep quality and fatigue between depression and renal function in nondialysis chronic kidney disease: a cross-sectional study

Authors: Ya-Fang Ho, Pei-Ti Hsu, Kai-Ling Yang

Published in: BMC Nephrology | Issue 1/2022

Abstract

Background

Depressive symptoms, fatigue, and poor sleep quality are associated with renal function deterioration in patients with nondialysis chronic kidney disease (CKD-ND). This study was designed to examine whether fatigue and sleep quality are mediators of the association between depression and renal function.

Methods

This study adopted a cross-sectional study design. Patients with CKD-ND aged 20 years or older were recruited by purposive sampling at a medical center in Central Taiwan from December 2020 to July 2021. Data were collected using the Emotional and Social Support Scale, Fatigue Scale, Beck Depression Inventory-II (BDI-II), and Pittsburgh Sleep Quality Index. Medical records were reviewed to obtain the estimated glomerular filtration rate (eGFR) for the next month. The relationships among variables were analyzed using structural equation modeling to assess the goodness-of-fit of the model. Then, the bootstrapping method was used to analyze the mediated effect.

Results

Two hundred forty-two participants (mean age 70.5 years and 53% males) were included in the analysis. About 39% of the participants met the criteria for depressive symptoms in BDI-II, and 91% reported having sleep disturbances. Participants’ degree of fatigue was not high (20.4 ± 13.3). The average eGFR was 25.45 mL/min/1.73 m ² (± 13.36). The results showed that fatigue, sleep quality, and eGFR were significantly correlated with depression. The total effect size was − 0.8304 (95% confidence interval [CI], − 0.9602 to − 0.7006), and the indirect effect size was − 0.1738 (95% CI, − 0.2812 to − 0.0651), which was a statistically significant difference, indicating that the model has a mediating effect. According to mediation analysis, fatigue and sleep quality had a significant indirect effect on the relationship between depression and renal function (95% CI, − 0.0587 to − 0.0039).

Conclusions

The findings suggest that fatigue and poor sleep quality may mediate the association between depression and renal function.

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72. https://doi.org/10.1016/S0140-6736(13)60687-X.

Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - A systematic review and meta-analysis. PLoS ONE. 2016;11(7):e0158765. https://doi.org/10.1371/journal.pone.0158765.

Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414-422D. https://doi.org/10.2471/BLT.17.206441.CrossRefPubMedPubMedCentral

Feng L, Yap KB, Ng TP. Depressive symptoms in older adults with chronic kidney disease: mortality, quality of life outcomes, and correlates. Am J Geriatr Psychiatry. 2013;21(6):570–9. https://doi.org/10.1016/j.jagp.2012.12.020.CrossRefPubMed

Karatas A, Canakci E, Turkmen E. Comparison of sleep quality and quality of life indexes with sociodemographic characteristics in patients with chronic kidney disease. Niger J Clin Pract. 2018;21(11):1461–7. https://doi.org/10.4103/njcp.njcp_146_18.CrossRefPubMed

Wang WL, Liang S, Zhu FL, Liu JQ, Wang SY, Chen XM, et al. The prevalence of depression and the association between depression and kidney function and health-related quality of life in elderly patients with chronic kidney disease: a multicenter cross-sectional study. Clin Interv Aging. 2019;14:905–13. https://doi.org/10.2147/CIA.S203186.CrossRefPubMedPubMedCentral

Turek NF, Ricardo AC, Lash JP. Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence. Am J Kidney Dis. 2012;60(5):823–33. https://doi.org/10.1053/j.ajkd.2012.04.027.CrossRefPubMedPubMedCentral

Chen Q, Zhang Y, Ding D, Xia M, Li D, Yang Y, et al. Estimated glomerular filtration rate and mortality among patients with coronary heart disease. PLoS ONE. 2016;11(8): e0161599. https://doi.org/10.1371/journal.pone.0161599.CrossRefPubMedPubMedCentral

Li J, Huang Z, Hou J, Sawyer AM, Wu Z, Cai J, et al. Sleep and CKD in Chinese adults: A cross-sectional study. Clin J Am Soc Nephrol. 2017;12(6):885–92. https://doi.org/10.2215/CJN.09270816.CrossRefPubMedPubMedCentral

10.

Tsai YC, Chiu YW, Hung CC, Hwang SJ, Tsai JC, Wang SL, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis. 2012;60(1):54–61. https://doi.org/10.1053/j.ajkd.2012.02.325.CrossRefPubMed

11.

Hedayati SS, Minhajuddin AT, Afshar M, Toto RD, Trivedi MH, Rush AJ. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA. 2010;303(19):1946–53. https://doi.org/10.1001/jama.2010.619.CrossRefPubMed

12.

Chiang HH, Guo HR, Livneh H, Lu MC, Yen ML, Tsai TY. Increased risk of progression to dialysis or death in CKD patients with depressive symptoms: A prospective 3-year follow-up cohort study. J Psychosom Res. 2015;79(3):228–32. https://doi.org/10.1016/j.jpsychores.2015.01.009.CrossRefPubMed

13.

Ogna A, Forni Ogna V, Haba Rubio J, Tobback N, Andries D, Preisig M, et al. Sleep characteristics in early stages of chronic kidney disease in the HypnoLaus cohort. Sleep. 2016;39(4):945–53. https://doi.org/10.5665/sleep.5660.CrossRefPubMedPubMedCentral

14.

Kumar B, Tilea A, Gillespie BW, Zhang X, Kiser M, Eisele G, Finkelstein F, Kotanko P, Levin N, Rajagopalan S, Saran R. Significance of self-reported sleep quality (SQ) in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study. Clin Nephrol. 2010;73(2):104–14. https://doi.org/10.5414/cnp73104.CrossRefPubMed

15.

Ricardo AC, Knutson K, Chen J, Appel LJ, Bazzano L, Carmona-Powell E, et al. The association of sleep duration and quality with CKD progression. J Am Soc Nephrol. 2017;28(12):3708–15. https://doi.org/10.1681/ASN.2016121288.CrossRefPubMedPubMedCentral

16.

Kahn M, Sheppes G, Sadeh A. Sleep and emotions: bidirectional links and underlying mechanisms. Int J Psychophysiol. 2013;89(2):218–28. https://doi.org/10.1016/j.ijpsycho.2013.05.010.CrossRefPubMed

17.

O’Leary K, Bylsma LM, Rottenberg J. Why might poor sleep quality lead to depression? A role for emotion regulation. Cogn Emot. 2017;31(8):1698–706. https://doi.org/10.1080/02699931.2016.1247035.

18.

Liu Q, Li YX, Hu ZH, Jiang XY, Li SJ, Wang XF. Reduced estimated glomerular filtration rate is associated with depressive symptoms in elder Chinese: A population-based cross-sectional study. Neurosci Lett. 2018;666:127–32. https://doi.org/10.1016/j.neulet.2017.12.029.CrossRefPubMed

19.

Tu CY, Chou YH, Lin YH, Huang WL. Sleep and emotional disturbance in patients with non-dialysis chronic kidney disease. J Formos Med Assoc. 2019;118(6):986–94. https://doi.org/10.1016/j.jfma.2018.10.016.CrossRefPubMed

20.

Nutt D, Wilson S, Paterson L. Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 2008;10(3):329–36. https://doi.org/10.31887/DCNS.2008.10.3/dnutt.CrossRefPubMedPubMedCentral

21.

Jhamb M, Liang K, Yabes J, et al. Prevalence and correlates of fatigue in chronic kidney disease and end-stage renal disease: are sleep disorders a key to understanding fatigue? Am J Nephrol. 2013;38(6):489–95. https://doi.org/10.1159/000356939.CrossRefPubMed

22.

Gregg LP, Jain N, Carmody T, Minhajuddin AT, Rush AJ, Trivedi MH, Hedayati SS. Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes. Am J Nephrol. 2019;50(1):37–47. https://doi.org/10.1159/000500668.CrossRefPubMed

23.

Gregg LP, Bossola M, Ostrosky-Frid M, Hedayati SS. Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment. Clin J Am Soc Nephrol. 2021;16(9):1445–55. https://doi.org/10.2215/CJN.19891220.CrossRefPubMed

24.

Umbro I, Fabiani V, Fabiani M, Angelico F, Del Ben M. A systematic review on the association between obstructive sleep apnea and chronic kidney disease. Sleep Med Rev. 2020;53: 101337. https://doi.org/10.1016/j.smrv.2020.101337.CrossRefPubMed

25.

Fang H, Tu S, Sheng J, Shao A. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med. 2019;23:2324–32. https://doi.org/10.1111/jcmm.14170.CrossRefPubMedPubMedCentral

26.

Steiger A, Pawlowski M. Depression and Sleep. Int J Mol Sci. 2019;20:607. https://doi.org/10.3390/ijms20030607.CrossRefPubMedCentral

27.

Schønning T, Dahl HJ, Hummelen B, Ulberg R. Do sleep disturbances improve following psychoanalytic psychotherapy for adolescent depression? Int J Environ Res Public Health. 2022;19:1790. https://doi.org/10.3390/ijerph19031790.CrossRefPubMedPubMedCentral

28.

Corfield EC, Martin NG, Nyholt DR. Co-occurrence and symptomatology of fatigue and depression. Compr Psychiatry. 2016;71:1–10. https://doi.org/10.1016/j.comppsych.2016.08.004.CrossRefPubMed

29.

Pan KC, Hung SY, Chen CI, Lu CY, Shih ML, Huang CY. Social support as a mediator between sleep disturbances, depressive symptoms, and health-related quality of life in patients undergoing hemodialysis. PLoS ONE. 2019;14(4): e0216045. https://doi.org/10.1371/journal.pone.0216045.CrossRefPubMedPubMedCentral

30.

Hsu PT, Ho CS, Ho YF, Chen JJ, Chen IJ. The effects of a social participation App on seniors. J Nurs Res. 2021;29(5):e168. https://doi.org/10.1097/JNR.0000000000000451.CrossRefPubMed

31.

Lin CC, Lee YH, Hung CC, Lee BO. Development of a novel fatigue scale for hemodialysis patients. Formos J Med. 2006;10:422–8.

32.

Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck depression inventories-IA and-II in psychiatric outpatients. J Pers Assess. 1996;67(3):588–97. https://doi.org/10.1207/s15327752jpa6703_13.CrossRefPubMed

33.

Lu M, Che H, Chang S, Shen W. Reliability and validity of the Chinese version of the Beck depression inventory-II. Taiwan J Psychiatry. 2002;16:301–10.

34.

Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. https://doi.org/10.1016/0165-1781(89)90047-4.CrossRefPubMed

35.

Tsai PS, Wang SY, Wang MY, Su CT, Yang TT, Huang CJ, et al. Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res. 2005;14(8):1943–52. https://doi.org/10.1007/s11136-005-4346-x.CrossRefPubMed

36.

Deskur-Smielecka E, Kotlinska-Lemieszek A, Chudek J, Wieczorowska-Tobis K. Assessment of renal function in geriatric palliative care patients - comparison of creatinine-based estimation equations. Clin Interv Aging. 2017;12:977–83. https://doi.org/10.2147/CIA.S130583.CrossRefPubMedPubMedCentral

37.

Cheungpasitporn W, Thongprayoon C, Gonzalez-Suarez ML, Srivali N, Ungprasert P, Kittanamongkolchai W, et al. The effects of short sleep duration on proteinuria and chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2017;32(6):991–6. https://doi.org/10.1093/ndt/gfw072.CrossRefPubMed

38.

Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004;141(12):929–37. https://doi.org/10.7326/0003-4819-141-12-200412210-00009.CrossRefPubMed

39.

Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5(6):1003–9. https://doi.org/10.2215/CJN.06870909.CrossRefPubMedPubMedCentral

40.

Drenth-van Maanen AC, Jansen PA, Proost JH, et al. Renal function assessment in older adults. Br J Clin Pharmacol. 2013;76(4):616–23. https://doi.org/10.1111/bcp.12199.CrossRefPubMedPubMedCentral

41.

Chiang HH, Livneh H, Yen ML, et al. Prevalence and correlates of depression among chronic kidney disease patients in Taiwan. BMC Nephrol. 2013;14:78. https://doi.org/10.1186/1471-2369-14-78.CrossRefPubMedPubMedCentral

42.

Simões E, Silva AC, Miranda AS, Rocha NP, Teixeira AL. Neuropsychiatric Disorders in Chronic Kidney Disease. Front Pharmacol. 2019;10:932. https://doi.org/10.3389/fphar.2019.00932.CrossRef

43.

Sukul N, Speyer E, Tu C, et al. Pruritus and Patient Reported Outcomes in Non-Dialysis CKD. Clin J Am Soc Nephrol. 2019;14(5):673–81. https://doi.org/10.2215/CJN.09600818.CrossRefPubMedPubMedCentral

44.

Plantinga L, Lee K, Inker LA, Saran R, Yee J, Gillespie B, Rolka D, Saydah S, Powe NR, CDC CKD Surveillance Team. Association of sleep-related problems with CKD in the United States, 2005–2008. Am J Kidney Dis. 2011;58(4):554–64. https://doi.org/10.1053/j.ajkd.2011.05.024.CrossRefPubMed

45.

Guo X, Li Z, Yu S, Yang H, Guo L, Zheng L, et al. Depression and quality of life in relation to decreased glomerular filtration rate among adults with hypertension in rural northeast China. Kidney Blood Press Res. 2015;40(1):31–40. https://doi.org/10.1159/000368480.CrossRefPubMed

46.

Yamamoto R, Shinzawa M, Isaka Y, Yamakoshi E, Imai E, Ohashi Y, et al. Sleep quality and sleep duration with CKD are associated with progression to ESKD. Clin J Am Soc Nephrol. 2018;13(12):1825–32. https://doi.org/10.2215/CJN.01340118.CrossRefPubMedPubMedCentral

47.

McMullan CJ, Curhan GC, Forman JP. Association of short sleep duration and rapid decline in renal function. Kidney Int. 2016;89(6):1324–30. https://doi.org/10.1016/j.kint.2015.12.048.CrossRefPubMedPubMedCentral

48.

Shafi ST, Shafi T. A comparison of quality of sleep between patients with chronic kidney disease not on hemodialysis and end-stage renal disease on hemodialysis in a developing country. Ren Fail. 2017;39(1):623–8. https://doi.org/10.1080/0886022X.2017.1361836.CrossRefPubMedPubMedCentral

49.

Tokonami N, Mordasini D, Pradervand S, Centeno G, Jouffe C, Maillard M, et al. Local renal circadian clocks control fluid-electrolyte homeostasis and BP. J Am Soc Nephrol. 2014;25(7):1430–9. https://doi.org/10.1681/ASN.2013060641.CrossRefPubMedPubMedCentral

50.

Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int. 2004;65(5):1568–76. https://doi.org/10.1111/j.1523-1755.2004.00552.x.CrossRefPubMed

51.

Jindal RD, Thase ME. Treatment of insomnia associated with clinical depression. Sleep Med Rev. 2004;8(1):19–30. https://doi.org/10.1016/S1087-0792(03)00025-X.CrossRefPubMed

52.

Rodgers S, Manjaly ZM, Calabrese P, et al. The effect of depression on health-related quality of life is mediated by fatigue in persons with multiple sclerosis. Brain Sci. 2021;11:751. https://doi.org/10.3390/brainsci11060751.CrossRefPubMedPubMedCentral

53.

Picariello F, Moss-Morris R, Macdougall IC, Chilcot AJ. The role of psychological factors in fatigue among end-stage kidney disease patients: a critical review. Clin Kidney J. 2017;10:79–88. https://doi.org/10.1093/ckj/sfw113.CrossRefPubMed

54.

Artom M, Moss-Morris R, Caskey F, Chilcot J. Fatigue in advanced kidney disease. Kidney Int. 2014;86:497–505. https://doi.org/10.1038/ki.2014.86.CrossRefPubMed

Title: The mediating effect of sleep quality and fatigue between depression and renal function in nondialysis chronic kidney disease: a cross-sectional study
Authors: Ya-Fang Ho
Pei-Ti Hsu
Kai-Ling Yang
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Mood Disorders
Affective Disorder
Chronic Kidney Disease
Fatigue
Published in: BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI: https://doi.org/10.1186/s12882-022-02757-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Significance of thyroid dysfunction in the patients with primary membranous nephropathy

Electrolyte derangements in critically ill children receiving balanced versus unbalanced crystalloid fluid resuscitation

The prevalence of Fabry disease in a statewide chronic kidney disease cohort – Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study

Correlation between intestinal flora disruption and protein–energy wasting in patients with end-stage renal disease

Bartonella endocarditis and diffuse crescentic proliferative glomerulonephritis with a full-house pattern of immune complex deposition

Double trouble - management of perinephric hematoma and renal vein thrombosis post percutaneous renal biopsy

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials